AAAAAA

   
Results: 1-9 |
Results: 9
Serum erythropoietin level in anemic cancer patients
Authors: Ozguroglu, M Arun, B Demir, G Demirelli, F Mandell, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Serum erythropoietin level in anemic cancer patients, MED ONCOL, 17(1), 2000, pp. 29-34
Detection of t(14;18) in Turkish follicular lymphomas using the polymerasechain reaction
Authors: Sayhan, N Tuzuner, N Aki, H Demir, G Berkarda, B
Citation: N. Sayhan et al., Detection of t(14;18) in Turkish follicular lymphomas using the polymerasechain reaction, LEUK RES, 24(6), 2000, pp. 475-479
Serum cardiolipin antibodies in cancer patients with thromboembolic events
Authors: Ozduroglu, M Arun, B Erzin, Y Demir, G Demirelli, F Mandel, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozduroglu et al., Serum cardiolipin antibodies in cancer patients with thromboembolic events, CL APPL T-H, 5(3), 1999, pp. 181-184
Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma
Authors: Ozguroglu, M Turna, H Demir, G Doventas, A Demirelli, F Mandel, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma, AM J CL ONC, 22(6), 1999, pp. 615-618
Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study)
Authors: Demir, G Ozguroglu, M Sayhan, N Molinas-Mandel, N Demirelli, F Buyukunal, E Tuzuner, N Serdengecti, S Berkarda, B
Citation: G. Demir et al., Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study), ANTICANC R, 19(4C), 1999, pp. 3517-3520
Preventive effect of hesperidin against inflammation in CD-1 mouse skin caused by tumor promoter
Authors: Koyuncu, H Berkarda, B Baykut, F Soybir, G Alatli, C Gul, H Altun, M
Citation: H. Koyuncu et al., Preventive effect of hesperidin against inflammation in CD-1 mouse skin caused by tumor promoter, ANTICANC R, 19(4B), 1999, pp. 3237-3241
Anorectal melanoma metastatic to the breast
Authors: Ozguroglu, M Ozaras, R Tahan, V Demirkesen, C Demir, G Dogusoy, G Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Anorectal melanoma metastatic to the breast, J CLIN GAST, 29(2), 1999, pp. 197-199
Primary splenic tuberculosis in a patient with nasal angiocentric lymphoma- Mimicking metastatic tumor on abdominal CT
Authors: Ozguroglu, M Celik, AF Demir, G Aki, H Demirelli, F Mandel, N Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Primary splenic tuberculosis in a patient with nasal angiocentric lymphoma- Mimicking metastatic tumor on abdominal CT, J CLIN GAST, 29(1), 1999, pp. 96-98
Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma
Authors: Demir, G Demirelli, F Ozguroglu, M Molinas-Mandel, N Buyukunal, E Tuzuner, N Serdengecti, S Berkarda, B
Citation: G. Demir et al., Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma, INT J IMM T, 14(3), 1998, pp. 163-168
Risultati: 1-9 |